Researchers at Harvard University developed an effective personalized cancer vaccine that seems to have prevented early tumour relapse in 12 skin cancer patients. The vaccine targeted 20 tumour-specific proteins unique to each of the patients enrolled, keeping all free of cancer over 2 years after the trial.
COFFEE BREAK NEWS FOR LIFE SCIENTISTS
A group of US researchers proposed a cutting edge alternative for eliminating resilient bacteria in the form of a “CRISPR pill”. The drug can specifically target harmful bugs using a combination of bacteria-seeking viruses and a cocktail of probiotics, making it more potent than most antibiotics.
Researchers at the University of Leuven (KU Leuven) have discovered that stevia stimulates a protein that is essential for our perception of taste and is involved in the release of insulin after a meal. These results create new possibilities for the treatment of diabetes.
Canadian researchers discovered that components of maple syrup may boost the antimicrobial effects of antibiotics by as much as 90% when used in combination. This synergy could provide an effective solution for the alarming threat of multi-drug resistant bacteria.
An international consortium of scientists have found a way to produce a semi-synthetic strain of baker´s yeast with more than a third of its chromosomes artificially synthesized.
US scientists have managed to transform spinach leaves into functional beating heart tissues with their own vascular networks, possibly opening up a new branch of tissue engineering science based on plant mimicry.
US scientists discovered a surprising hidden function of mammalian lungs – they help produce blood. Their study on mice showed that more than half of all platelets in mice are produced by the lungs, a process long attributed to bone marrow.
A new breast cancer drug combination significantly shrunk and eliminated tumours in 28% of women tested in just 11 days. The novel treatment involves a combination of pre-chemotherapy drugs lapatinib and trastuzumab that target HER2-positive tumours.
A pilot study set to uncover the potential of reversing type II diabetes resulted in remission of the disease in 40% of the patients taking part. The treatment involved a combination of intensive lifestyle interventions, oral medication, and insulin therapy.
British scientists developed a revolutionary method for screening cancer using breath-analyzing technology. In a preliminary study involving more than 300 patients the instrument was capable of diagnosing those with esophageal and stomach cancer with 85% accuracy.